Fig. 2
From: MHC-I genotype and tumor mutational burden predict response to immunotherapy
PFS for patients treated with immunotherapy in the validation dataset (N = 32). P values in the figure compare all four categories. a PFS dichotomized by PHBR < 0.5 and ≥ 0.5. b PFS dichotomized by TMB < 10 and ≥ 10 mutations/mb. c PFS separated by TMB < 10 and ≥ 10 and PHBR < 0.5 and ≥ 0.5